Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Avanos Medical Q2 Adj. EPS $0.17 Beats $0.15 Estimate, Sales $175.000M Beat $165.500M Estimate

Author: Benzinga Newsdesk | August 05, 2025 05:32am
Avanos Medical (NYSE:AVNS) reported quarterly earnings of $0.17 per share which beat the analyst consensus estimate of $0.15 by 13.33 percent. This is a 50 percent decrease over earnings of $0.34 per share from the same period last year. The company reported quarterly sales of $175.000 million which beat the analyst consensus estimate of $165.500 million by 5.74 percent. This is a 1.92 percent increase over sales of $171.700 million the same period last year.

Posted In: AVNS


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist